Uncovering the genetic diversity of the malaria parasite antigen MSP2 across Sub-Saharan Africa
Zerebinski J. et al, (2025)
R21/Matrix-M malaria vaccine drives diverse immune responses in pre-exposed adults: insights from a phase IIb controlled human malaria infection trial.
Kibwana E. et al, (2025), Front Immunol, 16
Reversible host cell surface remodelling limits immune recognition and maximizes survival of Plasmodium falciparum gametocytes
Ngotho P. et al, (2025), PLOS PATHOGENS, 21
Vaccine-induced responses to R21/Matrix-M - an analysis of samples from a phase 1b age de-escalation, dose-escalation trial.
Bundi C. et al, (2025), Frontiers in immunology, 16